Czarnecki Podiatry, Inc. | |
940 Bell Ave, Suite A, Hartford, WI 53027-2913 | |
(262) 673-7779 | |
(262) 673-5484 |
Full Name | Czarnecki Podiatry, Inc. |
---|---|
Type | Facility |
Speciality | Podiatrist - Foot & Ankle Surgery |
Location | 940 Bell Ave, Hartford, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1801018569 | NPI | - | NPPES |
43268400 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213ES0103X | Podiatrist - Foot & Ankle Surgery | 025-519 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Czarnecki Podiatry, Inc. 940 Bell Ave, Suite A, Hartford, WI 53027-2913 Ph: (262) 673-7779 | Czarnecki Podiatry, Inc. 940 Bell Ave, Suite A, Hartford, WI 53027-2913 Ph: (262) 673-7779 |
News Archive
Since spring, the White House has worked with stars like Jennifer Hudson and Amy Poehler to engage 18- to 34-year-olds. Now states like California are also getting into the act, enlisting rap artists and others.
Devon Medical Products, a global medical device designer, manufacturer, and distributor, today announced it has received Food & Drug Administration (FDA) 510(k) clearance to market its extriCARE 2400 Negative Pressure Wound Therapy (NPWT) system.
BioElectronics Corporation (BIEL) has announced that its specially designed eye mask for placement of ActiPatch Therapy after blepharoplasty surgery is now available.
Genzyme, a Sanofi company, announced it has received a Refuse to File letter from the U.S. Food and Drug Administration (FDA) in response to the supplemental Biologics License Application (sBLA) for the approval of LEMTRADA (alemtuzumab) as a treatment for relapsing multiple sclerosis.
› Verified 7 days ago